Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.

Translated title of the contribution: Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.

G. Feldmann, A. Mishra, S. Bisht, C. Karikari, I. Garrido-Laguna, Z. Rasheed, N.A. Ottenhof, T. Dadon, H. Alvarez, V. Fendrich, N.V. Rajeshkumar, W. Matsui, P. Brossart, M. Hidalgo, R. Bannerji, A. Maitra, B.D. Nelkin

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.
Original languageUndefined/Unknown
Pages (from-to)598-609
Number of pages12
JournalCancer Biology & Therapy
Volume12
Issue number7
Publication statusPublished - 2011

Cite this